The University of Chicago Header Logo

Mark J. Ratain

Concepts (1158)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
171
2024
2406
15.360
Why?
Neoplasms
194
2024
3009
14.400
Why?
Pharmacogenetics
76
2024
441
10.000
Why?
Glucuronosyltransferase
50
2015
185
6.560
Why?
Camptothecin
53
2020
191
6.260
Why?
Antineoplastic Agents, Phytogenic
45
2014
277
4.640
Why?
Clinical Trials, Phase II as Topic
24
2022
175
4.630
Why?
Antineoplastic Combined Chemotherapy Protocols
69
2021
2536
4.580
Why?
Clinical Trials, Phase I as Topic
32
2022
155
4.210
Why?
Humans
546
2024
88611
3.990
Why?
Research Design
31
2023
594
3.810
Why?
Clinical Trials as Topic
43
2023
1142
3.760
Why?
Dose-Response Relationship, Drug
66
2023
1945
3.360
Why?
Medical Oncology
17
2022
376
3.330
Why?
Drug Approval
7
2024
66
3.270
Why?
Maximum Tolerated Dose
27
2023
272
3.220
Why?
Pyridines
19
2022
316
3.210
Why?
Antibodies, Monoclonal, Humanized
18
2023
960
2.970
Why?
Drug-Related Side Effects and Adverse Reactions
13
2022
201
2.700
Why?
Food-Drug Interactions
8
2017
19
2.690
Why?
Lung Neoplasms
25
2023
2336
2.630
Why?
Carcinoma, Non-Small-Cell Lung
18
2023
1111
2.620
Why?
Protein Kinase Inhibitors
16
2022
603
2.570
Why?
Polymorphism, Genetic
31
2021
825
2.450
Why?
Benzenesulfonates
12
2012
66
2.410
Why?
Randomized Controlled Trials as Topic
18
2022
837
2.400
Why?
Piperidines
7
2022
163
2.300
Why?
Aged
207
2024
18932
2.230
Why?
United States Food and Drug Administration
14
2024
133
2.090
Why?
Drug Labeling
9
2017
41
2.080
Why?
Drug Administration Schedule
58
2020
902
2.070
Why?
Adenine
12
2022
88
2.030
Why?
Middle Aged
220
2024
25699
2.020
Why?
Genotype
53
2022
1867
1.960
Why?
Prostatic Neoplasms, Castration-Resistant
5
2018
119
1.900
Why?
Male
242
2024
42012
1.900
Why?
Antimetabolites, Antineoplastic
14
2020
237
1.880
Why?
Polymorphism, Single Nucleotide
36
2024
2399
1.830
Why?
Drugs, Investigational
11
2018
36
1.830
Why?
Enzyme Inhibitors
13
2017
646
1.820
Why?
Economics, Pharmaceutical
3
2023
10
1.810
Why?
Drug Monitoring
9
2024
119
1.800
Why?
Biomarkers, Tumor
21
2024
1520
1.800
Why?
Sirolimus
7
2018
173
1.790
Why?
Drug Interactions
24
2022
248
1.790
Why?
Androstenes
5
2021
43
1.790
Why?
Biopsy
11
2022
1187
1.770
Why?
Pharmacogenomic Testing
16
2022
98
1.770
Why?
Female
247
2024
45759
1.760
Why?
Precision Medicine
19
2022
407
1.750
Why?
Fluorouracil
29
2021
559
1.720
Why?
Adult
190
2022
26348
1.720
Why?
Aged, 80 and over
87
2021
6723
1.700
Why?
Neutropenia
28
2019
216
1.650
Why?
Deoxycytidine
11
2019
238
1.610
Why?
Antineoplastic Agents, Immunological
5
2022
190
1.570
Why?
Administration, Oral
32
2024
684
1.510
Why?
United States
38
2024
6882
1.480
Why?
Paclitaxel
22
2021
477
1.470
Why?
Biomedical Research
5
2023
389
1.470
Why?
Antibodies, Monoclonal
11
2021
1402
1.460
Why?
Cost-Benefit Analysis
7
2024
454
1.460
Why?
Etoposide
17
2009
198
1.400
Why?
Drug Industry
6
2021
54
1.400
Why?
Genome, Human
10
2019
767
1.380
Why?
Pharmacology, Clinical
4
2020
8
1.360
Why?
ErbB Receptors
8
2021
496
1.340
Why?
Treatment Outcome
59
2023
8178
1.330
Why?
Breast Neoplasms
25
2023
2980
1.290
Why?
Cytochrome P-450 CYP2D6
9
2022
52
1.280
Why?
Patient Selection
11
2018
689
1.280
Why?
Microsomes, Liver
17
2017
49
1.250
Why?
Thrombocytopenia
18
2022
185
1.250
Why?
Endpoint Determination
10
2016
60
1.250
Why?
Colorectal Neoplasms
17
2024
970
1.240
Why?
Suramin
11
2004
27
1.230
Why?
Quinazolines
10
2010
221
1.230
Why?
Sulfonamides
9
2017
318
1.210
Why?
Pyrimidines
6
2021
372
1.200
Why?
Infusions, Intravenous
38
2017
430
1.190
Why?
Melanoma
6
2020
463
1.180
Why?
Protein-Tyrosine Kinases
7
2012
307
1.180
Why?
Cisplatin
20
2021
616
1.150
Why?
Phenylurea Compounds
16
2018
114
1.110
Why?
Drug Dosage Calculations
5
2020
16
1.110
Why?
Genome-Wide Association Study
25
2024
1662
1.090
Why?
Angiogenesis Inhibitors
10
2021
315
1.090
Why?
Food
4
2018
86
1.090
Why?
Ketoconazole
6
2017
26
1.070
Why?
Molecular Targeted Therapy
5
2018
283
1.060
Why?
Drug Costs
3
2024
63
1.050
Why?
Drug Prescriptions
8
2022
144
1.030
Why?
Pharmaceutical Preparations
5
2024
91
1.010
Why?
Kidney Neoplasms
13
2014
634
1.000
Why?
Glucuronides
14
2017
34
0.990
Why?
Genetic Variation
17
2020
1369
0.990
Why?
Tamoxifen
6
2018
168
0.980
Why?
Niacinamide
15
2014
115
0.980
Why?
Models, Biological
26
2019
1764
0.970
Why?
Area Under Curve
28
2019
333
0.970
Why?
Genetic Therapy
2
2023
369
0.960
Why?
HIV Protease Inhibitors
2
2022
21
0.960
Why?
Isoenzymes
9
2015
273
0.960
Why?
Anemia
6
2022
126
0.950
Why?
Imides
9
2001
26
0.950
Why?
Phosphotransferases
2
2017
65
0.950
Why?
Prospective Studies
27
2022
4271
0.940
Why?
Orphan Drug Production
1
2023
4
0.930
Why?
Isoquinolines
9
2001
73
0.920
Why?
Carcinoma, Renal Cell
11
2014
434
0.920
Why?
Carbolines
3
2022
8
0.910
Why?
Decision Support Systems, Clinical
5
2019
105
0.910
Why?
Heterocyclic Compounds, 4 or More Rings
3
2022
16
0.900
Why?
Leukemia, Hairy Cell
26
1994
186
0.900
Why?
Conflict of Interest
5
2015
67
0.900
Why?
Indoles
6
2017
310
0.900
Why?
Clinical Trials, Phase III as Topic
8
2015
173
0.890
Why?
Body Surface Area
6
2022
36
0.890
Why?
Liver
18
2020
1244
0.890
Why?
Ethics Committees, Research
2
2022
33
0.870
Why?
Leukemia
9
2021
321
0.850
Why?
Prodrugs
5
2008
49
0.850
Why?
Quinoxalines
4
2014
50
0.840
Why?
Piperazines
3
2022
280
0.840
Why?
Ritonavir
1
2022
12
0.830
Why?
Bevacizumab
13
2024
287
0.820
Why?
Arylamine N-Acetyltransferase
2
2021
12
0.820
Why?
Physicians
3
2021
684
0.810
Why?
Leucovorin
18
2021
222
0.810
Why?
Fear
1
2022
80
0.800
Why?
Diarrhea
10
2009
182
0.800
Why?
Antibiotics, Antineoplastic
5
2012
116
0.800
Why?
Computer Simulation
6
2023
1095
0.800
Why?
Liver Diseases
4
2007
250
0.800
Why?
Prostatic Neoplasms
13
2024
1764
0.800
Why?
Patents as Topic
1
2021
12
0.790
Why?
Janus Kinase 2
1
2021
60
0.790
Why?
Patient Harm
1
2021
7
0.790
Why?
Peripheral Nervous System Diseases
6
2020
87
0.790
Why?
Anemia, Sickle Cell
1
2023
143
0.780
Why?
Antifungal Agents
3
2007
119
0.780
Why?
Industry
3
2023
17
0.780
Why?
Health Care Costs
3
2021
235
0.770
Why?
Biological Products
2
2020
147
0.770
Why?
Topotecan
9
2005
45
0.760
Why?
Cardiotoxicity
1
2021
10
0.760
Why?
Metabolic Clearance Rate
17
2017
120
0.750
Why?
Methyltransferases
5
2013
192
0.750
Why?
Informed Consent
11
2022
273
0.740
Why?
Taxoids
6
2016
130
0.730
Why?
Multidrug Resistance-Associated Proteins
5
2013
27
0.720
Why?
Pharmacogenomic Variants
4
2021
42
0.710
Why?
Creatinine
6
2015
295
0.700
Why?
Cytochrome P-450 CYP3A
10
2017
42
0.690
Why?
Adenosine A2 Receptor Antagonists
1
2019
13
0.670
Why?
Research
4
2019
251
0.670
Why?
Triazoles
4
2012
100
0.660
Why?
Interleukin-6
1
2020
260
0.660
Why?
Topoisomerase II Inhibitors
4
2009
27
0.660
Why?
Kidney Diseases
4
2007
319
0.660
Why?
Programmed Cell Death 1 Receptor
1
2020
169
0.650
Why?
Doxorubicin
9
2007
298
0.650
Why?
TOR Serine-Threonine Kinases
5
2018
185
0.650
Why?
Interferon-alpha
16
2004
236
0.640
Why?
Caffeine
1
2019
83
0.630
Why?
Point-of-Care Systems
3
2019
144
0.620
Why?
Physician's Role
2
2017
176
0.620
Why?
National Cancer Institute (U.S.)
7
2023
73
0.620
Why?
Megestrol Acetate
1
2017
10
0.610
Why?
Metabolome
2
2017
49
0.610
Why?
Patient Education as Topic
2
2019
356
0.610
Why?
Pyrazoles
5
2022
150
0.600
Why?
Protein Kinases
3
2009
212
0.600
Why?
Hydroxamic Acids
3
2014
51
0.600
Why?
Practice Patterns, Physicians'
7
2021
597
0.590
Why?
Parkinson Disease
1
2019
143
0.590
Why?
Medical Order Entry Systems
1
2017
25
0.590
Why?
Dihydrouracil Dehydrogenase (NADP)
10
2006
29
0.580
Why?
Nontherapeutic Human Experimentation
7
2017
20
0.580
Why?
Immunotherapy
2
2020
661
0.570
Why?
Neovascularization, Pathologic
5
2018
364
0.570
Why?
Carboplatin
5
2021
304
0.570
Why?
Practice Guidelines as Topic
8
2024
1039
0.570
Why?
Perioperative Care
5
2022
167
0.560
Why?
Guanine
4
2002
208
0.550
Why?
Recombinant Proteins
30
2017
1020
0.550
Why?
Kidney
6
2015
1145
0.540
Why?
Leukopenia
12
2002
66
0.530
Why?
Germ-Line Mutation
7
2020
341
0.530
Why?
Capecitabine
6
2020
98
0.520
Why?
Guidelines as Topic
2
2019
159
0.520
Why?
Pancreatic Neoplasms
4
2019
659
0.520
Why?
Topoisomerase I Inhibitors
7
2020
34
0.520
Why?
Attitude of Health Personnel
4
2019
642
0.520
Why?
Drug Resistance, Neoplasm
9
2020
612
0.520
Why?
RNA, Messenger
14
2018
2009
0.510
Why?
Oxidoreductases
10
2002
112
0.510
Why?
Introns
4
2013
298
0.510
Why?
Uracil
7
2002
56
0.510
Why?
Depsipeptides
1
2015
30
0.510
Why?
Aryl Hydrocarbon Hydroxylases
3
2013
44
0.510
Why?
Genetic Predisposition to Disease
15
2019
2322
0.510
Why?
Meaningful Use
1
2014
2
0.500
Why?
Morpholines
1
2015
69
0.500
Why?
Prostate-Specific Antigen
5
2018
358
0.500
Why?
Oligonucleotides, Antisense
2
2005
68
0.500
Why?
Carbazoles
2
2005
33
0.500
Why?
Head and Neck Neoplasms
10
2008
1057
0.490
Why?
Professional Practice
1
2015
46
0.490
Why?
Renal Insufficiency
2
2009
102
0.490
Why?
Lymphoma
7
2021
264
0.480
Why?
Time Factors
22
2020
5319
0.480
Why?
Hypertension, Pulmonary
3
2022
352
0.470
Why?
Cohort Studies
18
2019
2837
0.470
Why?
Bilirubin
13
2010
130
0.470
Why?
Reproducibility of Results
11
2021
2746
0.470
Why?
Regression Analysis
14
2010
594
0.470
Why?
Adenocarcinoma
5
2018
1184
0.470
Why?
Sample Size
3
2011
129
0.460
Why?
Hypertension
3
2021
733
0.460
Why?
Interferon Type I
17
1990
178
0.460
Why?
Patient Protection and Affordable Care Act
1
2014
67
0.450
Why?
Linkage Disequilibrium
7
2013
474
0.450
Why?
Young Adult
22
2020
6218
0.450
Why?
Estrogen Antagonists
1
2013
48
0.450
Why?
Program Development
1
2014
123
0.450
Why?
Biological Availability
7
2017
93
0.450
Why?
Risk Assessment
19
2021
2286
0.450
Why?
Dietary Fats
1
2014
136
0.450
Why?
Drug Delivery Systems
2
2012
179
0.450
Why?
Hearing Loss
1
2013
59
0.440
Why?
Catechol O-Methyltransferase
1
2013
69
0.440
Why?
Ambulatory Care
2
2014
186
0.440
Why?
Proto-Oncogene Proteins c-raf
2
2004
48
0.440
Why?
Models, Statistical
8
2020
575
0.440
Why?
Food Labeling
1
2012
8
0.440
Why?
Drug Therapy
5
2016
70
0.440
Why?
Indazoles
5
2017
67
0.430
Why?
Cladribine
5
2004
35
0.430
Why?
Phenotype
19
2020
2435
0.430
Why?
Enzymes
2
2006
47
0.430
Why?
Universities
1
2013
146
0.420
Why?
Private Sector
2
2011
19
0.420
Why?
Vascular Endothelial Growth Factor A
5
2018
421
0.420
Why?
Renal Insufficiency, Chronic
1
2015
223
0.420
Why?
Glucuronates
8
2007
22
0.410
Why?
Snake Venoms
2
2015
10
0.410
Why?
Medicine
3
2007
90
0.410
Why?
Clinical Protocols
2
2014
157
0.400
Why?
Investments
1
2011
6
0.400
Why?
Pyrazolones
2
2002
4
0.400
Why?
Warfarin
3
2019
104
0.400
Why?
Antineoplastic Agents, Hormonal
7
2018
156
0.400
Why?
Patient Safety
2
2020
215
0.400
Why?
Haplotypes
7
2012
637
0.390
Why?
Commerce
1
2011
30
0.390
Why?
Mass Media
1
2011
26
0.390
Why?
Vinblastine
7
1998
108
0.390
Why?
Technology, Pharmaceutical
2
2009
32
0.390
Why?
Neoplasm Staging
14
2021
1983
0.390
Why?
Academic Medical Centers
1
2014
383
0.390
Why?
Germ Cells
1
2012
130
0.380
Why?
Cost Sharing
1
2011
16
0.380
Why?
Kinetics
10
2017
1530
0.380
Why?
Interleukin-17
1
2011
105
0.380
Why?
Body Weight
4
2020
455
0.370
Why?
Gene Expression Regulation
5
2020
1977
0.370
Why?
Insurance, Health, Reimbursement
1
2011
60
0.370
Why?
Eating
2
2012
165
0.370
Why?
Clinical Decision-Making
5
2021
275
0.370
Why?
Mutation
8
2021
4097
0.370
Why?
Cyclosporine
5
2007
239
0.370
Why?
Health Resources
1
2011
82
0.370
Why?
Research Subjects
9
2007
73
0.370
Why?
Alleles
6
2017
1132
0.370
Why?
Patient Portals
2
2020
17
0.350
Why?
Follow-Up Studies
15
2021
3655
0.350
Why?
Aminopyridines
2
2022
40
0.350
Why?
Ovarian Neoplasms
3
2008
759
0.350
Why?
Cost Savings
2
2020
69
0.350
Why?
Blood Pressure Monitoring, Ambulatory
1
2009
29
0.350
Why?
Drug Evaluation
17
2002
138
0.340
Why?
Population Groups
1
2009
42
0.340
Why?
Dinucleotide Repeats
1
2009
14
0.340
Why?
Drug Design
8
2011
124
0.340
Why?
Hepatic Insufficiency
1
2009
1
0.340
Why?
Promoter Regions, Genetic
7
2012
956
0.340
Why?
Acetylation
6
2021
132
0.340
Why?
Decision Support Techniques
2
2021
165
0.330
Why?
Substrate Specificity
5
2017
352
0.330
Why?
Fatigue
8
2022
178
0.330
Why?
Genetics, Population
2
2009
404
0.330
Why?
Cell Line, Tumor
9
2018
2538
0.320
Why?
Double-Blind Method
9
2019
1716
0.320
Why?
Prescription Drugs
2
2019
36
0.320
Why?
Drug Discovery
1
2009
107
0.320
Why?
Phosphorylcholine
1
2008
28
0.320
Why?
Organizations, Nonprofit
1
2008
8
0.320
Why?
Anesthesiology
2
2022
160
0.320
Why?
Biomedical Technology
1
2008
21
0.320
Why?
Immunosuppressive Agents
4
2007
994
0.320
Why?
Biomarkers
2
2014
1759
0.310
Why?
Organoplatinum Compounds
4
2020
96
0.310
Why?
Disease Progression
6
2012
1490
0.310
Why?
Cytochrome P-450 Enzyme System
7
2008
79
0.310
Why?
Quantitative Trait Loci
6
2024
606
0.310
Why?
Data Interpretation, Statistical
5
2016
299
0.310
Why?
Myelodysplastic Syndromes
3
2014
351
0.300
Why?
Drug Packaging
3
2020
7
0.300
Why?
Government Regulation
2
2007
49
0.300
Why?
Salvage Therapy
4
2008
235
0.300
Why?
Evidence-Based Medicine
5
2021
431
0.300
Why?
Genetic Privacy
1
2007
12
0.300
Why?
Tubulin Modulators
2
2020
24
0.300
Why?
Liposomes
2
2004
93
0.290
Why?
Decision Making
5
2018
661
0.290
Why?
Glomerular Filtration Rate
2
2011
279
0.290
Why?
DNA-Binding Proteins
4
2012
1240
0.290
Why?
Models, Genetic
1
2012
942
0.290
Why?
Phenobarbital
4
2006
33
0.290
Why?
Health Knowledge, Attitudes, Practice
3
2020
525
0.290
Why?
Prejudice
1
2007
48
0.290
Why?
Medical Records
2
2007
121
0.280
Why?
Histone Deacetylase Inhibitors
3
2014
92
0.280
Why?
Intestinal Absorption
3
2017
124
0.280
Why?
Delivery of Health Care
3
2023
433
0.280
Why?
Naphthalimides
9
2001
17
0.280
Why?
Technology Transfer
1
2006
3
0.280
Why?
Patient Acceptance of Health Care
2
2020
253
0.270
Why?
Radiosurgery
2
2021
280
0.270
Why?
Disease-Free Survival
8
2016
1213
0.270
Why?
Drug Therapy, Combination
6
2019
799
0.270
Why?
Cytochrome P-450 CYP3A Inhibitors
2
2017
5
0.270
Why?
Erlotinib Hydrochloride
5
2010
90
0.270
Why?
Organophosphonates
9
2001
50
0.270
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2015
84
0.270
Why?
Abiraterone Acetate
2
2018
12
0.260
Why?
Neoplasms, Hormone-Dependent
1
2005
41
0.260
Why?
Carcinoma, Hepatocellular
2
2013
406
0.260
Why?
Prognosis
14
2021
3750
0.260
Why?
O(6)-Methylguanine-DNA Methyltransferase
3
2002
118
0.260
Why?
Pharmacy and Therapeutics Committee
3
2010
5
0.260
Why?
Cytochrome P-450 CYP2C9
2
2019
20
0.260
Why?
Receptor, trkA
1
2005
15
0.250
Why?
Survival Analysis
12
2018
1542
0.250
Why?
Liver Neoplasms
3
2013
771
0.250
Why?
Neuroendocrine Tumors
1
2006
109
0.250
Why?
Receptor Protein-Tyrosine Kinases
2
2010
162
0.250
Why?
Anthraquinones
2
2002
8
0.250
Why?
Dipeptides
1
2004
42
0.240
Why?
Chicago
4
2014
1411
0.240
Why?
Maytansine
1
2004
10
0.240
Why?
Thionucleotides
2
2002
56
0.240
Why?
Genomics
3
2019
747
0.240
Why?
Transforming Growth Factor beta2
1
2024
17
0.240
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
5
2004
112
0.240
Why?
Clinical Medicine
3
2015
34
0.240
Why?
Fasting
2
2018
163
0.240
Why?
Patient Compliance
2
2005
228
0.240
Why?
Information Dissemination
3
2019
111
0.240
Why?
Gene Expression Regulation, Enzymologic
4
2010
217
0.240
Why?
Risk Factors
12
2024
5449
0.240
Why?
Granulocyte Colony-Stimulating Factor
7
2003
166
0.230
Why?
Neoplasm Recurrence, Local
7
2018
1352
0.230
Why?
Acetyltransferases
2
2021
32
0.230
Why?
Glutathione Transferase
6
2005
112
0.230
Why?
Product Surveillance, Postmarketing
1
2023
38
0.230
Why?
Greenhouse Gases
1
2023
1
0.230
Why?
Animals
25
2016
27233
0.230
Why?
Genetic Markers
3
2018
478
0.230
Why?
Interleukin-2
7
2004
251
0.230
Why?
Pyrazines
4
2000
94
0.220
Why?
Government
1
2023
9
0.220
Why?
Physician-Patient Relations
4
2019
622
0.220
Why?
Neoplasm Metastasis
11
2024
1096
0.220
Why?
Sensory Receptor Cells
2
2014
36
0.220
Why?
Fever
3
2020
127
0.220
Why?
Neoplasms, Squamous Cell
2
2008
20
0.220
Why?
Prednisone
4
2018
258
0.220
Why?
RNA, Long Noncoding
1
2024
116
0.210
Why?
Dioxolanes
1
2002
8
0.210
Why?
Lymphoma, Non-Hodgkin
3
2010
262
0.210
Why?
Survival Rate
10
2021
1883
0.210
Why?
DNA Damage
2
2017
371
0.210
Why?
Apoptosis
2
2008
1718
0.210
Why?
Chemistry, Pharmaceutical
2
2004
60
0.210
Why?
Metabolic Networks and Pathways
3
2013
80
0.210
Why?
Lactams
1
2022
11
0.210
Why?
ATP-Binding Cassette Transporters
2
2016
142
0.210
Why?
DNA, Antisense
1
2002
15
0.210
Why?
Lactams, Macrocyclic
1
2022
14
0.210
Why?
Alanine
2
2019
85
0.210
Why?
Transcription, Genetic
3
2017
1156
0.210
Why?
Triazines
2
2019
53
0.210
Why?
Tramadol
1
2022
14
0.200
Why?
Anilides
2
2013
48
0.200
Why?
Reimbursement, Incentive
1
2022
37
0.200
Why?
Health Services Accessibility
2
2024
418
0.200
Why?
Leukemia, Myeloid
2
2014
249
0.200
Why?
Kv1.3 Potassium Channel
1
2021
14
0.200
Why?
Pain Management
2
2021
134
0.200
Why?
Celecoxib
2
2019
31
0.200
Why?
Uridine Diphosphate
2
1998
5
0.200
Why?
Genetic Testing
4
2019
538
0.200
Why?
Stomatitis
5
2004
30
0.200
Why?
Biotransformation
6
2009
50
0.200
Why?
Cytosine
1
2002
128
0.200
Why?
Proteinuria
1
2021
67
0.200
Why?
Mercaptopurine
3
2009
53
0.200
Why?
Oxidation-Reduction
3
2017
385
0.200
Why?
Oligodeoxyribonucleotides, Antisense
1
2001
16
0.200
Why?
Aminoquinolines
1
2001
17
0.200
Why?
Indenes
1
2001
10
0.190
Why?
Intercalating Agents
2
1993
12
0.190
Why?
Epothilones
2
2019
13
0.190
Why?
Acrylamides
1
2021
32
0.190
Why?
Human Genome Project
1
2001
19
0.190
Why?
Hockey
1
2021
9
0.190
Why?
Nitriles
2
2012
160
0.190
Why?
Protein Kinase C
1
2002
268
0.190
Why?
Research Personnel
2
2001
70
0.190
Why?
Anesthetics
1
2021
53
0.190
Why?
Patient Participation
4
2015
224
0.190
Why?
Government Agencies
1
2020
11
0.190
Why?
Hematologic Neoplasms
3
2014
336
0.190
Why?
Patient-Centered Care
1
2023
207
0.190
Why?
Collagen
1
2002
296
0.190
Why?
Anticarcinogenic Agents
3
2013
73
0.190
Why?
Antidotes
2
1997
23
0.190
Why?
Bile
2
2002
57
0.190
Why?
Organizational Policy
1
2001
55
0.190
Why?
Rheumatology
1
2021
35
0.180
Why?
Sarcoma
4
2009
220
0.180
Why?
Albumins
2
2019
130
0.180
Why?
Safety
4
2010
151
0.180
Why?
Analgesics, Opioid
2
2021
436
0.180
Why?
Signal Transduction
6
2013
3368
0.180
Why?
Genotyping Techniques
3
2018
69
0.180
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2008
173
0.180
Why?
Thymidylate Synthase
4
2003
13
0.180
Why?
Nausea
5
2022
176
0.180
Why?
Peptide Fragments
1
2002
460
0.180
Why?
Societies, Medical
2
2019
563
0.180
Why?
Analgesics
1
2021
119
0.180
Why?
Splenectomy
9
1992
82
0.180
Why?
Testicular Neoplasms
2
2019
113
0.180
Why?
Remission Induction
17
2008
735
0.180
Why?
Models, Theoretical
6
2014
490
0.180
Why?
Equivalence Trials as Topic
1
2019
5
0.180
Why?
Algorithms
3
2019
1868
0.180
Why?
Anesthesia
1
2022
169
0.180
Why?
Europe
1
2020
314
0.180
Why?
DNA, Neoplasm
3
2018
269
0.180
Why?
Schools, Medical
1
2001
134
0.170
Why?
Bone Marrow
12
2001
445
0.170
Why?
Drug Utilization
1
2020
65
0.170
Why?
C-Reactive Protein
1
2020
195
0.170
Why?
Leukocytes, Mononuclear
4
2018
205
0.170
Why?
Circadian Rhythm
2
2015
303
0.170
Why?
Receptors, Cytoplasmic and Nuclear
2
2017
124
0.170
Why?
Neoplasms, Second Primary
2
1992
258
0.170
Why?
Blood Pressure
3
2014
893
0.170
Why?
Response Evaluation Criteria in Solid Tumors
2
2018
57
0.170
Why?
Inpatients
1
2022
308
0.170
Why?
Leukocyte Count
10
1996
222
0.170
Why?
Chemotherapy, Adjuvant
5
2011
479
0.170
Why?
Cytidine Deaminase
1
2019
43
0.170
Why?
Hepatocytes
4
2013
128
0.170
Why?
Ethics, Medical
4
2008
308
0.170
Why?
Tegafur
2
1999
17
0.160
Why?
Stomach Neoplasms
1
2021
269
0.160
Why?
Quality Indicators, Health Care
1
2020
146
0.160
Why?
Leukemia, Myeloid, Acute
4
2008
782
0.160
Why?
Lymphoproliferative Disorders
3
1996
111
0.160
Why?
Withholding Treatment
1
2019
113
0.160
Why?
Benzamides
2
2013
239
0.160
Why?
Equilibrative Nucleoside Transporter 1
1
2018
2
0.160
Why?
Exanthema
2
2009
38
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2005
393
0.160
Why?
Receptors, IgG
1
2018
52
0.160
Why?
Medication Adherence
1
2020
134
0.160
Why?
Bayes Theorem
1
2020
368
0.160
Why?
Singapore
1
2018
16
0.160
Why?
Cetuximab
4
2021
113
0.160
Why?
Receptors, Estrogen
3
2016
386
0.160
Why?
Phosphatidylinositol 3-Kinases
2
2016
267
0.160
Why?
Dehydroepiandrosterone
1
2018
51
0.160
Why?
HSP90 Heat-Shock Proteins
1
2018
46
0.150
Why?
Troleandomycin
1
2017
3
0.150
Why?
Bone Marrow Diseases
3
1993
40
0.150
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
127
0.150
Why?
Proton Magnetic Resonance Spectroscopy
1
2017
12
0.150
Why?
Career Choice
1
2019
145
0.150
Why?
Liver Function Tests
4
2007
93
0.150
Why?
Erythropoietin
3
2013
89
0.150
Why?
Statistics as Topic
3
1993
235
0.150
Why?
History, 20th Century
2
2011
307
0.150
Why?
Receptors, Calcitriol
1
2018
129
0.150
Why?
Receptors, Vascular Endothelial Growth Factor
2
2014
72
0.150
Why?
Surveys and Questionnaires
9
2020
2593
0.150
Why?
Diphtheria Toxin
4
1998
20
0.150
Why?
Terminology as Topic
1
2019
219
0.150
Why?
Combined Modality Therapy
11
2021
1709
0.150
Why?
Adrenal Cortex Diseases
1
1996
6
0.140
Why?
Addison Disease
1
1996
4
0.140
Why?
Ribosomal Protein S6 Kinases, 70-kDa
2
2018
46
0.140
Why?
Specialization
2
2007
65
0.140
Why?
Motor Neuron Disease
1
1997
21
0.140
Why?
Valproic Acid
1
1997
24
0.140
Why?
Therapeutic Human Experimentation
2
1993
20
0.140
Why?
Cardiovascular Agents
2
2015
54
0.140
Why?
Neural Conduction
1
1997
71
0.140
Why?
Cytochrome P-450 CYP2C19
2
2014
8
0.140
Why?
Demyelinating Diseases
1
1997
67
0.140
Why?
Glioma
1
1999
291
0.140
Why?
Intersectoral Collaboration
1
2016
10
0.140
Why?
Periodicals as Topic
1
2019
168
0.140
Why?
Metformin
1
2018
123
0.140
Why?
Biliary Tract
1
1996
13
0.140
Why?
Healthy Volunteers
1
2017
145
0.140
Why?
Testosterone
1
2018
275
0.140
Why?
Gene Expression Regulation, Neoplastic
4
2010
1256
0.140
Why?
Neoplasm Proteins
5
2016
539
0.140
Why?
Critical Care
1
2019
378
0.140
Why?
Cyclophosphamide
7
2002
300
0.130
Why?
Atazanavir Sulfate
1
2015
1
0.130
Why?
Hyperbilirubinemia
1
2015
21
0.130
Why?
Floxuridine
2
1993
12
0.130
Why?
Jaundice
1
2015
14
0.130
Why?
Polyneuropathies
1
2016
27
0.130
Why?
Hydroxyurea
6
1998
239
0.130
Why?
Chromatography, High Pressure Liquid
5
2004
315
0.130
Why?
Drug Eruptions
2
2006
34
0.130
Why?
Flavonoids
4
2007
87
0.130
Why?
Glucocorticoids
1
2018
358
0.130
Why?
Attitude to Health
4
2017
221
0.130
Why?
Random Allocation
6
2008
329
0.130
Why?
Pneumonia, Viral
1
2020
318
0.130
Why?
Placebos
3
2017
214
0.130
Why?
Tumor Microenvironment
1
2019
450
0.130
Why?
Selection Bias
2
2011
37
0.130
Why?
Advisory Committees
1
2015
88
0.130
Why?
Sulfonic Acids
1
1995
9
0.130
Why?
Collagen Type I
1
2015
72
0.130
Why?
Naphthyridines
1
2015
27
0.130
Why?
Treatment Failure
2
2011
289
0.120
Why?
Nitrosamines
1
2014
8
0.120
Why?
Hydrocortisone
1
1996
303
0.120
Why?
Gene Expression Profiling
6
2013
1427
0.120
Why?
Nedocromil
1
2014
6
0.120
Why?
Inactivation, Metabolic
2
2006
8
0.120
Why?
Loss of Heterozygosity
1
2014
86
0.120
Why?
Sex Characteristics
1
1997
321
0.120
Why?
DNA Primers
2
2006
543
0.120
Why?
Drug Resistance
3
1993
232
0.120
Why?
Comprehension
5
2000
80
0.120
Why?
Lymphopenia
2
2012
31
0.120
Why?
Busulfan
1
2014
41
0.120
Why?
Adolescent
11
2020
9157
0.120
Why?
Fees and Charges
1
2014
14
0.120
Why?
Drug Synergism
5
2018
305
0.120
Why?
Epirubicin
3
2021
14
0.120
Why?
Phthalazines
1
2014
43
0.120
Why?
Aldehyde Oxidase
1
2014
3
0.120
Why?
Forced Expiratory Volume
1
2014
124
0.120
Why?
Neoplasms, Glandular and Epithelial
1
2015
75
0.120
Why?
Azacitidine
1
2014
139
0.120
Why?
Pyrroles
2
2015
186
0.120
Why?
Cytochrome P-450 CYP2C8
1
2013
3
0.120
Why?
Receptors, Interleukin-2
5
1998
67
0.120
Why?
Thromboembolism
1
2014
119
0.120
Why?
Disclosure
5
2000
109
0.120
Why?
Sex Factors
5
2020
1063
0.120
Why?
Organic Cation Transporter 1
1
2013
1
0.120
Why?
Anti-Asthmatic Agents
1
2014
75
0.120
Why?
Child
9
2020
7089
0.110
Why?
Hepatocyte Nuclear Factor 1
1
2013
30
0.110
Why?
Portraits as Topic
1
2013
6
0.110
Why?
Patient Outcome Assessment
1
2014
84
0.110
Why?
Carcinoma, Squamous Cell
2
1999
1094
0.110
Why?
Carcinoma, Small Cell
3
1997
133
0.110
Why?
Arteries
1
2014
181
0.110
Why?
Medicare
1
2017
420
0.110
Why?
Brain Diseases
1
1995
184
0.110
Why?
Erythropoiesis
1
2013
51
0.110
Why?
Comorbidity
1
2017
947
0.110
Why?
Imatinib Mesylate
1
2013
127
0.110
Why?
Brain Neoplasms
1
1999
779
0.110
Why?
Organic Anion Transporters, Sodium-Independent
1
2013
5
0.110
Why?
Prevalence
1
2017
1248
0.110
Why?
Pathology, Molecular
1
2013
34
0.110
Why?
Axons
1
2014
179
0.110
Why?
Leukemia, Prolymphocytic
1
1992
3
0.110
Why?
Transfection
4
2011
914
0.110
Why?
Health Policy
1
2015
185
0.110
Why?
Off-Label Use
1
2012
16
0.110
Why?
Adaptation, Physiological
1
1995
316
0.110
Why?
Trastuzumab
2
2023
70
0.110
Why?
Leukemia, B-Cell
1
1992
23
0.110
Why?
Nicotine
1
2014
199
0.110
Why?
Citrus paradisi
1
2012
5
0.110
Why?
Conserved Sequence
1
2013
211
0.110
Why?
DNA Topoisomerases, Type II
2
2009
21
0.110
Why?
Binding, Competitive
2
2010
146
0.110
Why?
Androstenols
1
2012
3
0.110
Why?
Skin Neoplasms
5
2020
577
0.110
Why?
Quality of Life
5
2020
1649
0.100
Why?
Kaplan-Meier Estimate
2
2011
865
0.100
Why?
Leukemia, Monocytic, Acute
1
1992
14
0.100
Why?
Multifactorial Inheritance
1
2014
167
0.100
Why?
National Institutes of Health (U.S.)
2
2017
123
0.100
Why?
Orchiectomy
1
2012
72
0.100
Why?
Cells, Cultured
3
2020
2879
0.100
Why?
Venous Thromboembolism
1
2014
158
0.100
Why?
Gene Dosage
2
2013
208
0.100
Why?
Hyperlipidemias
1
2012
93
0.100
Why?
Hydroxylation
2
2009
17
0.100
Why?
Logistic Models
4
1999
1205
0.100
Why?
Soft Tissue Neoplasms
2
2009
129
0.100
Why?
Postmenopause
1
2012
101
0.100
Why?
Students
1
2013
163
0.100
Why?
Phosphorylation
2
2018
1129
0.100
Why?
Therapeutic Equivalency
2
2021
12
0.100
Why?
Anticoagulants
2
2019
423
0.100
Why?
Peptides
1
2015
646
0.100
Why?
Hemoglobins
2
1991
189
0.100
Why?
Pentostatin
7
2002
30
0.100
Why?
Rats
5
2013
4041
0.100
Why?
Proto-Oncogene Proteins c-ret
1
2011
22
0.100
Why?
Patient Care
1
2012
101
0.100
Why?
Oligonucleotide Array Sequence Analysis
3
2008
697
0.100
Why?
Fibroblasts
1
2014
755
0.100
Why?
Thalidomide
1
2011
57
0.100
Why?
Adenoma
1
2013
243
0.100
Why?
Androstadienes
1
2011
72
0.100
Why?
Cyclosporins
1
1991
58
0.100
Why?
Verapamil
1
1991
34
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2008
891
0.100
Why?
Hyperglycemia
1
2012
171
0.100
Why?
Multivariate Analysis
5
2009
995
0.100
Why?
Tumor Cells, Cultured
4
2002
1057
0.100
Why?
Maryland
1
2011
42
0.100
Why?
Life Expectancy
1
2011
87
0.100
Why?
Pharmacoepidemiology
1
2010
6
0.090
Why?
Analgesics, Non-Narcotic
1
2011
47
0.090
Why?
Acetaminophen
1
2011
55
0.090
Why?
Gene Frequency
4
2008
684
0.090
Why?
Thyroxine
2
2015
347
0.090
Why?
Predictive Value of Tests
5
2021
1709
0.090
Why?
DNA Repair
2
2003
359
0.090
Why?
Insurance, Health
1
2012
160
0.090
Why?
Feasibility Studies
5
2004
774
0.090
Why?
Amino Acid Substitution
1
2011
338
0.090
Why?
Hepatocyte Nuclear Factor 1-alpha
2
2009
80
0.090
Why?
Cholestasis
1
1990
47
0.090
Why?
Microtubules
2
2004
121
0.090
Why?
Healthcare Disparities
1
2015
396
0.090
Why?
Efficiency
1
2010
40
0.090
Why?
Cardiovascular Diseases
2
2015
707
0.090
Why?
Smoking
1
2014
618
0.090
Why?
Glycosylation
1
2010
129
0.090
Why?
Burkitt Lymphoma
1
2010
32
0.090
Why?
Antibodies, Monoclonal, Murine-Derived
1
2010
77
0.090
Why?
Electroencephalography
1
1995
741
0.090
Why?
Proto-Oncogene Proteins B-raf
2
2013
146
0.090
Why?
Half-Life
5
2008
96
0.090
Why?
Indinavir
2
2010
3
0.090
Why?
Daunorubicin
2
2008
78
0.090
Why?
History, 21st Century
1
2011
177
0.090
Why?
Vomiting
4
2014
193
0.090
Why?
Severity of Illness Index
3
2020
1843
0.090
Why?
Rituximab
1
2010
119
0.090
Why?
Cell Cycle Proteins
2
2010
399
0.090
Why?
Software
2
2017
663
0.090
Why?
Kidney Function Tests
2
2007
114
0.090
Why?
Motivation
4
2012
295
0.090
Why?
Publishing
1
2010
91
0.090
Why?
Cell Proliferation
3
2016
1647
0.090
Why?
Membrane Proteins
1
2016
1214
0.080
Why?
Lymphoma, B-Cell
1
2010
105
0.080
Why?
International Normalized Ratio
1
2009
39
0.080
Why?
Mucositis
1
2009
18
0.080
Why?
Podophyllotoxin
3
1994
10
0.080
Why?
Pain
2
2022
401
0.080
Why?
Blood Cell Count
6
1999
79
0.080
Why?
Polymerase Chain Reaction
2
2013
927
0.080
Why?
Topoisomerase Inhibitors
1
2008
2
0.080
Why?
RecQ Helicases
1
2008
7
0.080
Why?
Forecasting
2
2008
305
0.080
Why?
Acute Disease
4
2014
838
0.080
Why?
Werner Syndrome
1
2008
2
0.080
Why?
Genes, Neoplasm
1
2008
37
0.080
Why?
Pilot Projects
4
2019
866
0.080
Why?
Platinum Compounds
1
2008
31
0.080
Why?
Exodeoxyribonucleases
1
2008
16
0.080
Why?
Recombinant Fusion Proteins
4
1998
565
0.080
Why?
Developed Countries
1
2008
24
0.080
Why?
Health Care Sector
1
2008
13
0.080
Why?
Enterohepatic Circulation
1
2008
3
0.080
Why?
Hep G2 Cells
3
2013
48
0.080
Why?
Colonic Neoplasms
1
2012
566
0.080
Why?
Personal Autonomy
4
1998
116
0.080
Why?
MicroRNAs
1
2013
551
0.080
Why?
Protease Inhibitors
1
2008
74
0.080
Why?
Injections, Subcutaneous
3
2004
119
0.080
Why?
Stereoisomerism
3
2008
102
0.080
Why?
Immunotoxins
2
1998
14
0.080
Why?
Lymphoma, Follicular
1
2008
73
0.080
Why?
Economics, Medical
1
2007
6
0.080
Why?
Tomography, X-Ray Computed
2
2016
2638
0.080
Why?
MAP Kinase Signaling System
1
2008
197
0.080
Why?
Carmustine
2
2000
70
0.070
Why?
Phosphoproteins
1
2009
260
0.070
Why?
Receptor, ErbB-2
2
2014
237
0.070
Why?
Everolimus
1
2007
42
0.070
Why?
Hematopoietic Stem Cell Transplantation
1
2014
884
0.070
Why?
Gene Amplification
1
2007
133
0.070
Why?
Hypotension
3
2004
70
0.070
Why?
Insurance
1
2007
12
0.070
Why?
Evolution, Molecular
1
2013
836
0.070
Why?
Age Factors
4
2014
1863
0.070
Why?
Tissue Distribution
2
2021
292
0.070
Why?
Hodgkin Disease
1
2008
181
0.070
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2008
157
0.070
Why?
In Situ Hybridization, Fluorescence
2
2010
354
0.070
Why?
Base Sequence
3
2008
2331
0.070
Why?
Employment
1
2007
53
0.070
Why?
Immunoenzyme Techniques
2
2002
306
0.070
Why?
Observer Variation
1
2008
609
0.070
Why?
Adaptor Proteins, Signal Transducing
1
2009
311
0.070
Why?
Radiotherapy
2
2003
331
0.070
Why?
Medication Errors
1
2007
39
0.070
Why?
Nogalamycin
1
1986
2
0.070
Why?
Serum Albumin
3
1995
128
0.070
Why?
Tea
1
2006
21
0.070
Why?
Molecular Structure
1
2007
289
0.070
Why?
Patient Reported Outcome Measures
2
2019
190
0.070
Why?
Lymphoma, Large B-Cell, Diffuse
1
2008
154
0.070
Why?
Thymidine
1
1986
60
0.070
Why?
Cross-Over Studies
2
2011
390
0.070
Why?
Catechin
1
2006
24
0.070
Why?
Photosensitivity Disorders
1
2006
16
0.070
Why?
Structure-Activity Relationship
1
2007
411
0.070
Why?
Case-Control Studies
3
2020
1851
0.070
Why?
Keratosis
1
2006
21
0.070
Why?
Complementary Therapies
1
2007
56
0.070
Why?
Probability
1
2007
356
0.070
Why?
Infusion Pumps
5
1989
25
0.070
Why?
DNA Topoisomerases, Type I
1
2006
24
0.070
Why?
Asthma
1
2014
973
0.070
Why?
Drug Combinations
3
2010
203
0.070
Why?
Genes, ras
1
2006
98
0.070
Why?
Molecular Sequence Data
3
2008
3029
0.070
Why?
Retrospective Studies
8
2013
8893
0.070
Why?
Patients
1
2007
102
0.070
Why?
Mice
6
2016
11710
0.070
Why?
Foot Dermatoses
1
1985
3
0.070
Why?
Rats, Wistar
2
1997
302
0.070
Why?
Protein Structure, Tertiary
1
2007
741
0.070
Why?
Hand Dermatoses
1
1985
9
0.070
Why?
Neutrophils
3
2002
308
0.070
Why?
Adsorption
1
2005
54
0.060
Why?
Alternative Splicing
2
2008
210
0.060
Why?
Furans
1
2005
16
0.060
Why?
Oligodeoxyribonucleotides
1
2005
127
0.060
Why?
Consensus Sequence
1
2005
65
0.060
Why?
Filgrastim
2
2003
57
0.060
Why?
Phenylenediamines
1
2004
6
0.060
Why?
Thiophenes
3
2000
43
0.060
Why?
Meperidine
1
2004
13
0.060
Why?
Injections, Intravenous
3
2004
241
0.060
Why?
Oxidoreductases, N-Demethylating
1
2004
14
0.060
Why?
Cytochrome P-450 Enzyme Inhibitors
1
2004
10
0.060
Why?
Drug Hypersensitivity
1
2004
37
0.060
Why?
Capsules
1
2004
38
0.060
Why?
Transaminases
1
2004
33
0.060
Why?
Quinolones
1
2004
60
0.060
Why?
In Vitro Techniques
3
2015
995
0.060
Why?
B-Lymphocytes
2
2008
737
0.060
Why?
Mixed Function Oxygenases
1
2004
69
0.060
Why?
Coformycin
3
1989
9
0.060
Why?
Tissue Fixation
2
2014
40
0.060
Why?
Gene Transfer Techniques
1
2004
153
0.060
Why?
Paraffin Embedding
2
2014
78
0.060
Why?
Formaldehyde
2
2014
52
0.060
Why?
Neoplasm Transplantation
1
2004
397
0.060
Why?
Pyrrolidines
1
2004
59
0.060
Why?
Drug Screening Assays, Antitumor
2
2010
78
0.060
Why?
Research Support as Topic
1
2004
82
0.060
Why?
Greenhouse Effect
1
2023
2
0.060
Why?
Ethics, Research
1
2004
52
0.060
Why?
Mouth Mucosa
2
2014
67
0.060
Why?
Idoxuridine
2
1993
16
0.060
Why?
Pelvis
1
2003
94
0.060
Why?
Hypnotics and Sedatives
1
2004
130
0.060
Why?
Alkaline Phosphatase
4
2002
133
0.060
Why?
CD56 Antigen
1
2002
18
0.050
Why?
Chromium
1
2002
17
0.050
Why?
Endostatins
1
2002
6
0.050
Why?
Child, Preschool
3
2020
3678
0.050
Why?
Therapies, Investigational
1
2022
17
0.050
Why?
Pharmacists
1
2022
32
0.050
Why?
CHO Cells
1
2002
187
0.050
Why?
Omeprazole
1
2022
11
0.050
Why?
Succinylcholine
1
2022
14
0.050
Why?
Hepatitis C
1
2005
219
0.050
Why?
Syndrome
1
2003
448
0.050
Why?
Hydralazine
1
2022
19
0.050
Why?
Morphine
1
2003
130
0.050
Why?
Protein Kinase C-alpha
1
2002
27
0.050
Why?
Epoprostenol
1
2022
46
0.050
Why?
X-ray Repair Cross Complementing Protein 1
1
2021
2
0.050
Why?
Killer Cells, Natural
2
2002
275
0.050
Why?
Population
1
2002
35
0.050
Why?
Familial Primary Pulmonary Hypertension
1
2022
60
0.050
Why?
Flow Cytometry
2
2002
691
0.050
Why?
Immunohistochemistry
2
2004
1790
0.050
Why?
Oxycodone
1
2022
35
0.050
Why?
Anorexia
1
2001
30
0.050
Why?
Oligonucleotides
1
2002
92
0.050
Why?
Cricetinae
1
2002
560
0.050
Why?
Point Mutation
1
2002
246
0.050
Why?
Gastrointestinal Hemorrhage
1
2024
237
0.050
Why?
Carbon Radioisotopes
1
2001
35
0.050
Why?
Interinstitutional Relations
1
2001
29
0.050
Why?
Receptors, Interleukin-6
1
2020
17
0.050
Why?
Anthropometry
1
2001
76
0.050
Why?
Data Collection
2
2000
374
0.050
Why?
Complement System Proteins
1
2001
83
0.050
Why?
Cardiac Output
1
2001
156
0.050
Why?
Disease Models, Animal
1
2008
2346
0.050
Why?
Blood Coagulation
1
2001
92
0.050
Why?
Neurites
1
2020
36
0.050
Why?
Ferredoxin-NADP Reductase
1
2020
15
0.050
Why?
Sequence Analysis, DNA
2
2018
863
0.050
Why?
Longitudinal Studies
2
2014
1051
0.050
Why?
Aspartate Aminotransferases
1
2000
74
0.050
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2020
27
0.050
Why?
Carcinoma
1
2004
441
0.050
Why?
Proprotein Convertase 9
1
2020
20
0.040
Why?
Lactones
1
2000
27
0.040
Why?
Evaluation Studies as Topic
1
2000
270
0.040
Why?
Macrolides
1
2000
31
0.040
Why?
Antihypertensive Agents
1
2022
244
0.040
Why?
Interferons
4
1990
134
0.040
Why?
Glutathione
2
2000
109
0.040
Why?
Administration, Intravenous
1
2019
51
0.040
Why?
Colonic Polyps
1
2000
130
0.040
Why?
Polyethylene Glycols
1
2001
365
0.040
Why?
Gene Expression
2
2014
1312
0.040
Why?
Hypoxia
1
2004
650
0.040
Why?
Analysis of Variance
2
2004
902
0.040
Why?
Drug Recalls
1
2019
13
0.040
Why?
Health Plan Implementation
1
2019
56
0.040
Why?
Codeine
1
2019
12
0.040
Why?
Myosin Type II
1
2019
50
0.040
Why?
Hypolipidemic Agents
1
2020
99
0.040
Why?
Myosin Heavy Chains
1
2019
92
0.040
Why?
Feces
1
2001
326
0.040
Why?
Receptors, G-Protein-Coupled
1
2020
127
0.040
Why?
Hospitalization
2
2019
871
0.040
Why?
Aldehyde Dehydrogenase
1
1998
15
0.040
Why?
NFATC Transcription Factors
1
2018
49
0.040
Why?
Hematologic Diseases
2
1996
78
0.040
Why?
Alkyl and Aryl Transferases
1
1998
15
0.040
Why?
Ribonucleosides
2
1989
25
0.040
Why?
Organic Anion Transporters
2
2009
26
0.040
Why?
Crigler-Najjar Syndrome
1
1998
3
0.040
Why?
Mycosis Fungoides
1
1998
29
0.040
Why?
Zidovudine
1
1998
16
0.040
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2018
5
0.040
Why?
Nitrophenols
1
1998
11
0.040
Why?
Anticonvulsants
1
1999
125
0.040
Why?
Human Umbilical Vein Endothelial Cells
1
2018
68
0.040
Why?
Program Evaluation
1
2019
303
0.040
Why?
Treatment Refusal
1
1998
62
0.040
Why?
Anti-Inflammatory Agents
1
2020
342
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2021
478
0.040
Why?
Exons
2
2011
452
0.040
Why?
Dose-Response Relationship, Radiation
1
2018
188
0.040
Why?
Causality
1
1998
80
0.040
Why?
Infant
2
2020
3117
0.040
Why?
Cancer Survivors
1
2019
94
0.040
Why?
Alcohol Dehydrogenase
1
1997
42
0.040
Why?
DNA Methylation
1
2002
656
0.040
Why?
Consent Forms
2
1995
11
0.040
Why?
Vinca Alkaloids
1
1997
3
0.040
Why?
Cosyntropin
1
1996
5
0.040
Why?
Multicenter Studies as Topic
2
2015
156
0.040
Why?
Isotretinoin
1
1997
23
0.040
Why?
Pain, Postoperative
1
2019
248
0.040
Why?
Thiotepa
2
2004
32
0.040
Why?
Radiotherapy Dosage
1
2018
471
0.040
Why?
Aldosterone
1
1996
56
0.040
Why?
Patient Satisfaction
1
2000
460
0.040
Why?
Health Personnel
1
2019
209
0.030
Why?
Adrenocorticotropic Hormone
1
1996
131
0.030
Why?
Tetrahydrofolates
1
1996
13
0.030
Why?
Disease Management
1
2019
328
0.030
Why?
Morphine Derivatives
2
2008
8
0.030
Why?
Hospital Mortality
1
2019
381
0.030
Why?
Neoplasm Grading
1
2018
367
0.030
Why?
User-Computer Interface
1
2017
187
0.030
Why?
Social Perception
1
2017
96
0.030
Why?
Magnetic Resonance Imaging
1
2008
3445
0.030
Why?
Antigens, Neoplasm
2
2009
330
0.030
Why?
Keratoacanthoma
1
1996
4
0.030
Why?
Neuropsychological Tests
1
2018
507
0.030
Why?
Mitoxantrone
1
1996
68
0.030
Why?
Biological Transport
2
2002
400
0.030
Why?
Vitamin D
1
2018
267
0.030
Why?
Lymphatic Metastasis
1
2018
499
0.030
Why?
Digestive System Diseases
1
1996
18
0.030
Why?
Life Tables
1
1995
48
0.030
Why?
Tertiary Care Centers
1
2016
101
0.030
Why?
Quality Control
1
2016
116
0.030
Why?
Transcriptional Activation
1
2016
290
0.030
Why?
Bleomycin
2
1993
102
0.030
Why?
Microsomes
1
2015
35
0.030
Why?
Membrane Transport Proteins
1
2016
169
0.030
Why?
Transcription Factors
2
2014
1647
0.030
Why?
Communication
1
2019
452
0.030
Why?
Interferon-gamma
2
1988
452
0.030
Why?
Chi-Square Distribution
1
1996
360
0.030
Why?
Lung
2
2014
1243
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p15
1
2014
24
0.030
Why?
Bias
2
1995
130
0.030
Why?
Blast Crisis
1
1995
36
0.030
Why?
Rats, Sprague-Dawley
1
1998
1237
0.030
Why?
Chromatography, Liquid
2
2010
106
0.030
Why?
Chromosome Mapping
2
2011
1077
0.030
Why?
Immunocompromised Host
1
1996
143
0.030
Why?
Coma
1
1995
45
0.030
Why?
Linear Models
1
1996
423
0.030
Why?
Blotting, Western
2
2008
797
0.030
Why?
Body Mass Index
1
1998
770
0.030
Why?
Peroxisome-Targeting Signal 1 Receptor
1
2014
3
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2014
80
0.030
Why?
Myeloablative Agonists
1
2014
36
0.030
Why?
Tumor Burden
1
2016
304
0.030
Why?
Budesonide
1
2014
46
0.030
Why?
Nervous System Diseases
1
1995
157
0.030
Why?
Antineoplastic Protocols
1
2014
9
0.030
Why?
Prostatectomy
1
2018
476
0.030
Why?
Blindness
1
1994
40
0.030
Why?
Lymphocytes
3
2004
470
0.030
Why?
Cyclohexanecarboxylic Acids
1
1994
18
0.030
Why?
Prostate
1
2018
392
0.030
Why?
Cell Line
2
2010
2498
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2016
386
0.030
Why?
DNA, Complementary
2
2007
392
0.030
Why?
Reference Standards
1
2014
143
0.030
Why?
Electronic Health Records
1
2017
340
0.030
Why?
Erythrocyte Count
1
2013
22
0.030
Why?
Body Height
1
2014
100
0.030
Why?
Arylsulfotransferase
1
2013
4
0.030
Why?
Clonal Evolution
1
2013
15
0.030
Why?
Sulfotransferases
1
2013
19
0.030
Why?
Blood Platelets
1
1994
150
0.030
Why?
Proportional Hazards Models
2
2008
858
0.030
Why?
Dacarbazine
1
1994
102
0.030
Why?
Odds Ratio
1
2015
686
0.030
Why?
Solute Carrier Organic Anion Transporter Family Member 1B3
1
2013
4
0.030
Why?
Drug Stability
1
2013
48
0.030
Why?
Anthracenes
1
1993
16
0.030
Why?
Astrocytoma
1
1993
82
0.030
Why?
DNA Copy Number Variations
1
2014
177
0.030
Why?
Regulatory Factor X Transcription Factors
1
2012
12
0.030
Why?
Frozen Sections
1
2013
49
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2013
64
0.030
Why?
Ethical Review
1
1992
8
0.030
Why?
Cattle
1
2013
375
0.030
Why?
Blood
1
1993
69
0.030
Why?
Receptor, EphA5
1
2012
2
0.030
Why?
Blood Transfusion
2
1991
164
0.030
Why?
Insurance Claim Review
1
2012
46
0.030
Why?
Imidazoles
1
2013
151
0.030
Why?
Databases, Factual
1
2016
846
0.030
Why?
Gene-Environment Interaction
1
2013
109
0.030
Why?
Dogs
1
2013
704
0.030
Why?
Sepsis
1
1996
317
0.030
Why?
ras Proteins
1
2013
130
0.030
Why?
Chromosomes, Human, Pair 21
1
1992
54
0.030
Why?
Insurance Benefits
1
2012
8
0.030
Why?
Chromosomes, Human, Pair 11
1
1992
106
0.030
Why?
Up-Regulation
1
2014
729
0.030
Why?
Least-Squares Analysis
1
1991
48
0.030
Why?
Intellectual Property
1
2011
3
0.020
Why?
Hydrogen-Ion Concentration
1
2013
499
0.020
Why?
Monocytes
3
1994
217
0.020
Why?
Evidence-Based Practice
1
2012
45
0.020
Why?
Species Specificity
1
2013
685
0.020
Why?
DNA Mutational Analysis
1
2013
531
0.020
Why?
Pan troglodytes
1
2013
199
0.020
Why?
Comparative Effectiveness Research
1
2012
53
0.020
Why?
Carcinoma, Merkel Cell
1
1991
17
0.020
Why?
Carcinoma, Neuroendocrine
1
2011
29
0.020
Why?
Taiwan
1
2011
23
0.020
Why?
Mice, Knockout
1
2016
1988
0.020
Why?
Luminescent Measurements
1
2011
62
0.020
Why?
Translocation, Genetic
1
1992
266
0.020
Why?
Allelic Imbalance
1
2011
22
0.020
Why?
3' Untranslated Regions
1
2011
95
0.020
Why?
Genetic Loci
1
2012
253
0.020
Why?
Public Sector
1
2010
12
0.020
Why?
Glioblastoma
1
1993
265
0.020
Why?
Macaca mulatta
1
2013
465
0.020
Why?
Microfilament Proteins
1
2012
212
0.020
Why?
Toxicity Tests
1
2010
13
0.020
Why?
Principal Component Analysis
1
2011
160
0.020
Why?
Receptors, Growth Factor
1
2010
52
0.020
Why?
Gas Chromatography-Mass Spectrometry
2
2002
42
0.020
Why?
Epigenesis, Genetic
1
2014
502
0.020
Why?
Antibody Formation
1
1991
171
0.020
Why?
Hymecromone
1
2010
4
0.020
Why?
Tandem Mass Spectrometry
1
2010
105
0.020
Why?
Glucuronic Acid
1
2010
11
0.020
Why?
Cloning, Molecular
1
2011
647
0.020
Why?
Imipramine
1
2010
16
0.020
Why?
Serine Endopeptidases
1
2010
146
0.020
Why?
Oncogene Proteins, Fusion
1
2010
131
0.020
Why?
Intestinal Mucosa
1
2015
804
0.020
Why?
Biocatalysis
1
2010
51
0.020
Why?
Gene Deletion
1
2011
342
0.020
Why?
Genetic Vectors
1
2011
446
0.020
Why?
Aging
1
1994
712
0.020
Why?
Protein Binding
1
2013
1484
0.020
Why?
Microtubule-Associated Proteins
1
2010
183
0.020
Why?
Cooperative Behavior
1
2010
179
0.020
Why?
Demography
1
2009
181
0.020
Why?
Mice, Inbred C57BL
1
2016
3202
0.020
Why?
Leukemia L1210
1
1988
12
0.020
Why?
DNA Breaks, Double-Stranded
1
2009
66
0.020
Why?
Proto-Oncogene Proteins c-met
1
2010
200
0.020
Why?
Melphalan
1
1989
98
0.020
Why?
Werner Syndrome Helicase
1
2008
2
0.020
Why?
Survivors
1
2010
233
0.020
Why?
Osteolysis
1
1988
14
0.020
Why?
Midazolam
1
2008
48
0.020
Why?
Thiones
2
2000
10
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1988
95
0.020
Why?
Sensitivity and Specificity
1
2013
2019
0.020
Why?
Rats, Inbred Dahl
1
2008
8
0.020
Why?
Complement C1q
1
2008
11
0.020
Why?
Transforming Growth Factor beta3
1
2008
16
0.020
Why?
Thiosemicarbazones
1
2008
6
0.020
Why?
Methemoglobinemia
1
2008
10
0.020
Why?
Bone Marrow Transplantation
1
1989
283
0.020
Why?
Hypertrophy, Right Ventricular
1
2008
33
0.020
Why?
Recurrence
2
2008
1168
0.020
Why?
Incidence
1
2012
1592
0.020
Why?
Luciferases, Firefly
1
2007
12
0.020
Why?
Karyotyping
1
1987
253
0.020
Why?
Xenobiotics
1
2007
7
0.020
Why?
Lymphoma, T-Cell, Cutaneous
2
1998
28
0.020
Why?
Gadolinium DTPA
1
2008
264
0.020
Why?
Informatics
1
2007
5
0.020
Why?
Cytarabine
1
2008
219
0.020
Why?
Herb-Drug Interactions
1
2007
4
0.020
Why?
Antigens, Surface
1
1987
103
0.020
Why?
Mycophenolic Acid
1
2007
88
0.020
Why?
Aerosols
1
2007
44
0.020
Why?
Bone Marrow Examination
1
1987
47
0.020
Why?
Molecular Diagnostic Techniques
1
2007
73
0.020
Why?
Hydroxytestosterones
1
2006
1
0.020
Why?
Plant Preparations
1
2007
20
0.020
Why?
Mitogen-Activated Protein Kinases
1
2008
226
0.020
Why?
Pharmacokinetics
1
2006
10
0.020
Why?
Menogaril
1
1986
3
0.020
Why?
Genes, Reporter
1
2007
275
0.020
Why?
Infusions, Parenteral
1
1986
51
0.020
Why?
Thymine
1
1986
17
0.020
Why?
Digestive System
1
1986
42
0.020
Why?
Hyponatremia
1
1986
27
0.020
Why?
Administration, Inhalation
1
2007
188
0.020
Why?
Uterine Cervical Neoplasms
1
1989
294
0.020
Why?
Enzyme Activation
1
2008
698
0.020
Why?
Thyroid Neoplasms
1
2011
418
0.020
Why?
Empirical Research
2
1997
19
0.020
Why?
Vitamins
1
2007
82
0.020
Why?
Dietary Supplements
1
2007
130
0.020
Why?
Cell Survival
1
2008
980
0.020
Why?
Platelet Aggregation Inhibitors
1
2007
142
0.020
Why?
Mephenytoin
1
2004
2
0.020
Why?
Cytochrome P-450 CYP2B6
1
2004
6
0.020
Why?
Fluvoxamine
1
2004
7
0.020
Why?
Receptors, Endothelin
1
2004
12
0.020
Why?
Lung Diseases
1
2007
269
0.020
Why?
Sequence Deletion
1
2005
205
0.020
Why?
Hemodynamics
1
2008
728
0.010
Why?
Statistics, Nonparametric
1
2004
307
0.010
Why?
Vincristine
2
1997
112
0.010
Why?
Analgesia, Patient-Controlled
1
2003
16
0.010
Why?
Indicators and Reagents
1
2003
72
0.010
Why?
Carrier Proteins
1
2007
679
0.010
Why?
Contrast Media
1
2008
1088
0.010
Why?
Substance-Related Disorders
1
2007
409
0.010
Why?
Heart Ventricles
1
2008
779
0.010
Why?
Risk
1
2004
660
0.010
Why?
Dexamethasone
1
2004
344
0.010
Why?
Propofol
1
2002
91
0.010
Why?
Global Health
1
2002
186
0.010
Why?
Catalysis
1
2001
205
0.010
Why?
Cyclin-Dependent Kinases
1
2000
43
0.010
Why?
Hot Temperature
1
2000
208
0.010
Why?
Rectum
1
2000
148
0.010
Why?
Spectrophotometry, Ultraviolet
1
1998
44
0.010
Why?
Shivering
1
1998
4
0.010
Why?
Dermatitis, Exfoliative
1
1998
3
0.010
Why?
Methotrexate
2
1989
250
0.010
Why?
Pentoxifylline
1
1998
9
0.010
Why?
Platelet Count
2
1989
93
0.010
Why?
Cell Count
1
1998
199
0.010
Why?
Neoplasms, Experimental
1
1999
269
0.010
Why?
Persons
1
1997
6
0.010
Why?
Control Groups
1
1997
15
0.010
Why?
Federal Government
1
1997
29
0.010
Why?
Paternalism
1
1997
24
0.010
Why?
Vasodilator Agents
1
1998
146
0.010
Why?
Chromatography, Ion Exchange
1
1997
34
0.010
Why?
Patient Advocacy
1
1997
52
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1997
80
0.010
Why?
Radiography
1
1999
807
0.010
Why?
Vulnerable Populations
1
1997
80
0.010
Why?
Ligands
1
1998
440
0.010
Why?
Neoplasm Invasiveness
1
1998
575
0.010
Why?
Mass Spectrometry
1
1997
193
0.010
Why?
Brain
1
1986
2268
0.010
Why?
Enzyme Induction
1
1995
88
0.010
Why?
Karnofsky Performance Status
1
1995
40
0.010
Why?
Menopause
1
1995
76
0.010
Why?
Catheterization, Central Venous
1
1996
115
0.010
Why?
CD4-CD8 Ratio
1
1994
18
0.010
Why?
Cultural Diversity
1
1995
53
0.010
Why?
Educational Status
1
1995
191
0.010
Why?
Truth Disclosure
1
1995
91
0.010
Why?
Cyclohexenes
1
1994
5
0.010
Why?
Lymphocyte Subsets
1
1994
66
0.010
Why?
Benzofurans
1
1994
9
0.010
Why?
Trust
1
1995
97
0.010
Why?
Professional Staff Committees
1
1992
7
0.010
Why?
Cancer Care Facilities
1
1992
29
0.010
Why?
Hemoglobin A
1
1992
8
0.010
Why?
2-Chloroadenosine
1
1992
5
0.010
Why?
Deoxyadenosines
1
1992
23
0.010
Why?
Platinum
1
1992
63
0.010
Why?
Diabetes Complications
1
1993
172
0.010
Why?
Respiratory Insufficiency
1
1993
159
0.010
Why?
Electrocardiography
1
1993
495
0.010
Why?
Absorption
1
1989
25
0.010
Why?
Acid Phosphatase
1
1988
34
0.010
Why?
Chlorambucil
1
1988
23
0.010
Why?
Chromatography, Gas
1
1988
28
0.010
Why?